Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
F de Marval<SUP>1</SUP>, B Gottstein<SUP>2</SUP>, M Weber<SUP>3</SUP>, B Wicht (
)<SUP>4</SUP>
Citation style for this article: de Marval F, Gottstein B, Weber M, Wicht B. Imported diphyllobothriasis in Switzerland: molecular methods to define a clinical case of Diphyllobothrium infection as Diphyllobothrium dendriticum, August 2010 . Euro Surveill. 2013;18(3)
ii=20355. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20355
Date of submission: 07 May 2012 <HR>Following a first clinical case of infection by Diphyllobothrium dendriticum in Switzerland in 2006, we report a second case in the country. The species was identified by molecular methods. In the Swiss, French and Italian subalpine regions, human diphyllobothriasis has seen a comeback since the late 1980?s, and Diphyllobothrium latum is usually considered the causative agent of the disease. In addition, several locally acquired and imported clinical infections due to allochthonous Diphyllobothrium species have been documented in the last years. Due to the colonisation potential of these parasites and their probably underestimated presence in the human population, there is a need for discriminating them at the medical laboratory level. Because the morphological characters are very similar among the different taxa, a correct identification requires the use of molecular methods. Molecular identification would improve diagnosis and help monitor the distribution of Diphyllobothrium species in Europe.
- ------
Eurosurveillance, Volume 18, Issue 3, 17 January 2013
Surveillance and outbreak reports
Imported diphyllobothriasis in Switzerland: molecular methods to define a clinical case of Diphyllobothrium infection as Diphyllobothrium dendriticum, August 2010
Surveillance and outbreak reports
Imported diphyllobothriasis in Switzerland: molecular methods to define a clinical case of Diphyllobothrium infection as Diphyllobothrium dendriticum, August 2010
F de Marval<SUP>1</SUP>, B Gottstein<SUP>2</SUP>, M Weber<SUP>3</SUP>, B Wicht (
- Dianalabs, Geneva, Switzerland
- Institute of Parasitology, University of Bern, Bern, Switzerland
- Private practice, Ch?ne-Bourg, Switzerland
- Istituto cantonale di microbiologia, Bellinzona, Switzerland
Citation style for this article: de Marval F, Gottstein B, Weber M, Wicht B. Imported diphyllobothriasis in Switzerland: molecular methods to define a clinical case of Diphyllobothrium infection as Diphyllobothrium dendriticum, August 2010 . Euro Surveill. 2013;18(3)
ii=20355. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20355 Date of submission: 07 May 2012 <HR>Following a first clinical case of infection by Diphyllobothrium dendriticum in Switzerland in 2006, we report a second case in the country. The species was identified by molecular methods. In the Swiss, French and Italian subalpine regions, human diphyllobothriasis has seen a comeback since the late 1980?s, and Diphyllobothrium latum is usually considered the causative agent of the disease. In addition, several locally acquired and imported clinical infections due to allochthonous Diphyllobothrium species have been documented in the last years. Due to the colonisation potential of these parasites and their probably underestimated presence in the human population, there is a need for discriminating them at the medical laboratory level. Because the morphological characters are very similar among the different taxa, a correct identification requires the use of molecular methods. Molecular identification would improve diagnosis and help monitor the distribution of Diphyllobothrium species in Europe.